Diapin Therapeutics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Financing Rounds
  • 1

Diapin Therapeutics General Information

Description

Developer of peptide-based therapies intended to treat Type 2 diabetes. The company is in pre-clinical trials to develop three amino acid peptide.

Contact Information

Website
www.diapin.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Primary Office
  • 1600 Huron Parkway
  • B520 Second Floor
  • Ann Arbor, MI 48109
  • United States
+1 (734) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Diapin Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Diapin Therapeutics‘s full profile, request access.

Request a free trial

Diapin Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of peptide-based therapies intended to treat Type 2 diabetes. The company is in pre-clinical trials to develop
Drug Discovery
Ann Arbor, MI
000
000 0000-00-00
000000000 000

00000000

. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla paria
0000000000000
South San Francisco, CA
00000 As of 0000
000.00
0000 0000-00-00
00000000000

00000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
000000000000000
Tarrytown, NY
0000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Diapin Therapeutics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
000000000 00000000 Formerly VC-backed Tarrytown, NY 0000 00000 00000000000 00000
000000 00000000 Venture Capital-Backed Williamsville, NY 00 00.000 000000000 - 00.000
0000000 0000000000 Formerly VC-backed Wayne, PA 00 00000 00000000000 00000
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
To view Diapin Therapeutics’s complete competitors history, request access »

Diapin Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Alex Ma Ph.D Vice President & Chief Scientific Officer
John Johnson Ph.D Vice President of Development
Bruce Markham Ph.D President, Board Member and Chief Executive Officer
Yuqing Chen Ph.D Founder & Board Member
To view Diapin Therapeutics’s complete executive team members history, request access »

Diapin Therapeutics Board Members (3)

Name Representing Role Since
0000000 00000000 00.0 Self Board Member 000 0000
000000 00 Diapin Therapeutics Board Member 000 0000
000000 0000 00.0 Self Founder & Board Member 000 0000
To view Diapin Therapeutics’s complete board members history, request access »

Diapin Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Diapin Therapeutics‘s full profile, request access.

Request a free trial